We have uncovered a deSUMOylated phospho-PR gene signature of both known and novel PR target genes that is a marker of hyperactive PR signaling in breast cancer cell models; this signature is indeed also present in a subset of patients with recurrent breast cancer (Figures. Here, PGR is linked to breast cancer.